BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5856129)

  • 21. GENERATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES BY HEMOLYTIC AGENTS.
    COHEN G; HOCHSTEIN P
    Biochemistry; 1964 Jul; 3():895-900. PubMed ID: 14214074
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS.
    Glader BE; Conrad ME
    J Lab Clin Med; 1973 Feb; 81(2):267-72. PubMed ID: 4683425
    [No Abstract]   [Full Text] [Related]  

  • 23. Red cell enzyme deficiencies: a review.
    Stiene EA
    Am J Med Technol; 1972 Nov; 38(11):454-61. PubMed ID: 4404285
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes of protein tyrosine phosphorylation in erythrocyte band 3 glucose-6-phosphate dehydrogenase deficiency].
    Yu G; Li J; Tian X; Lin H; Wang X
    Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):565-7. PubMed ID: 12482337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of glucose-6-phosphate dehydrogenase deficiency to prevent possible drug-induced hemolysis].
    Hadad Meléndez P; Martínez JL; Millán Marcelo JC; Aguiar Cruz F
    Rev Cubana Med Trop; 1991; 43(3):205. PubMed ID: 9768192
    [No Abstract]   [Full Text] [Related]  

  • 26. [Glucose-6-phosphate dehydrogenase deficiency in Mecklenburg].
    Schulz K; Nowotny P; Preussner S
    Dtsch Gesundheitsw; 1968 Jan; 23(2):56-9. PubMed ID: 5680687
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemolytic effect of sulfonamides in patients with erythrocytes deficient in glucose-6-phosphate dehydrogenase.
    Norden CW; Desforges JF; Kass EH
    N Engl J Med; 1968 Jul; 279(1):30-1. PubMed ID: 5658018
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
    Fraser IM; Vesell ES
    J Pharmacol Exp Ther; 1968 Jul; 162(1):155-65. PubMed ID: 5656594
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of drugs and drug metabolites on erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient individuals.
    Fraser IM; Vesell ES
    Ann N Y Acad Sci; 1968 Jul; 151(2):777-94. PubMed ID: 4391843
    [No Abstract]   [Full Text] [Related]  

  • 30. [The erythrocyte catalase in normal subjects and patients with glucose-6-phosphate dehydrogenase deficiency: quantitative determination of the enzyme and its chromatographic characterization].
    Idéo G; Coghe A; Dioguardi N
    Haematologica; 1967; 52(4):285-300. PubMed ID: 4976385
    [No Abstract]   [Full Text] [Related]  

  • 31. [Red cell enzyme deficiencies - clinical manifestation and pathophysiology (author's transl)].
    Gahr M
    Monatsschr Kinderheilkd; 1981 Aug; 129(8):444-53. PubMed ID: 6116183
    [No Abstract]   [Full Text] [Related]  

  • 32. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine, primaquine enantiomers, and its two putative metabolites. II. Effect on red blood cell membrane, lipid peroxidation, MC-540 staining, and scanning electron microscopic studies.
    Agarwal S; Gupta UR; Daniel CS; Gupta RC; Anand N; Agarwal SS
    Biochem Pharmacol; 1991 Jan; 41(1):17-21. PubMed ID: 1986741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
    Bashan N; Peleg N; Moses SW
    Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
    Jacobasch G; Bleiber R; Schönian G
    Haematologia (Budap); 1982 Dec; 15(4):401-7. PubMed ID: 7186479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the heterogeneity of hemoglobin from normal and glucose-6-phosphate dehydrogenase-deficient individuals.
    Zaidman J
    Clin Chim Acta; 1969 Jan; 23(1):67-73. PubMed ID: 5762140
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical laboratory indices of hemolysis in persons with various types of haptoglobin in preventive primaquine therapy of malaria].
    Shcherbakov AM; Ozeretskovskaia NN; Bronshteĭn AM; Benediktov II; Lachinova RI
    Med Parazitol (Mosk); 1975; 44(3):288-92. PubMed ID: 1177820
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction of oxidized glutathione in normal and glucose-6-phosphate dehydrogenase deficient erythrocytes and their hemolysates.
    Rieber EE; Jaffé ER
    Blood; 1970 Feb; 35(2):166-72. PubMed ID: 5414698
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative study on the carbohydrate metabolism of glutathione-deficient, glucose-6-phosphate dehydrogenase-deficient and normal human red cells.
    Loos JA; Zürcher C; Prins HK
    Biochim Biophys Acta; 1966 May; 121(1):187-9. PubMed ID: 5956941
    [No Abstract]   [Full Text] [Related]  

  • 39. Types of erythrocytic glucose-6-phosphate dehydrogenase in normal and in deficient Turkish subjects.
    Berkel I; Say B; Bowman JE; Carson PE
    Turk J Pediatr; 1967 Jan; 9(1):13-7. PubMed ID: 6056491
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of hemolysis in vitro for the purpose of detecting primaquine sensitivity].
    Allakhverdiev AM; Grinberg LN
    Lab Delo; 1981; (12):724-6. PubMed ID: 6172643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.